惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Hugging Face - Blog
Hugging Face - Blog
Google DeepMind News
Google DeepMind News
云风的 BLOG
云风的 BLOG
WordPress大学
WordPress大学
Vercel News
Vercel News
Apple Machine Learning Research
Apple Machine Learning Research
T
Tailwind CSS Blog
I
InfoQ
小众软件
小众软件
Recent Announcements
Recent Announcements
博客园 - 【当耐特】
The GitHub Blog
The GitHub Blog
大猫的无限游戏
大猫的无限游戏
美团技术团队
T
The Blog of Author Tim Ferriss
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
酷 壳 – CoolShell
酷 壳 – CoolShell
MongoDB | Blog
MongoDB | Blog
V
V2EX
J
Java Code Geeks
有赞技术团队
有赞技术团队
博客园 - 聂微东
B
Blog RSS Feed
博客园 - 司徒正美

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Valmet Oyj (VLMTY) Q1 2026 Earnings Call Transcript
2026-04-28 · via All Articles on Seeking Alpha

Valmet Oyj (VLMTY) Q1 2026 Earnings Call April 28, 2026 4:00 AM EDT

Company Participants

Pekka Rouhiainen - Vice President of Investor Relations
Thomas Hinnerskov - CEO & President
Katri Hokkanen - Chief Financial Officer

Conference Call Participants

Antti Kansanen - SEB, Research Division
Mikael Doepel - Nordea Markets, Research Division
Tomas Skogman - DNB Carnegie, Research Division

Presentation

Pekka Rouhiainen
Vice President of Investor Relations

Good morning, everyone, and welcome to Valmet's Q1 results webcast. Before we start, a short practical note, today's webcast is audio only due to a flu in the team. Thanks for your understanding. I'm Pekka Rouhiainen from Investor Relations, and with me today are Valmet's President and CEO, Thomas Hinnerskov; as well as CFO, Katri Hokkanen.

Today, Thomas will start with an overview of Valmet from the customer and investor viewpoint and go through the first quarter performance. Katri will then discuss the financials in more detail. After that, Thomas will return to cover the guidance and short-term market outlook before we open the lines for the questions. And as usual, you can submit written questions through the webcast platform at any time.

But with that, let's get started. Thomas, the floor is yours.

Thomas Hinnerskov
CEO & President

Thank you, Pekka, and good morning, everyone, from me as well. The headline message for this first quarter is that we continue to execute our strategy in an overall demanding market environment, while sales mix had a clear impact on our profitability. Customer decision-making remained cautious and the geopolitical situation decreased visibility. Against that backdrop, our Process Performance business continued to deliver strong margins, while Biomaterials business was impacted by project phasing and the mix. Importantly, the benefits from the early and decisive operating model actions we took last year are clearly and continue to be clearly visible, supporting earnings quality also in a softer market.